Trial intelligence / Profile preview

Intranasal Dexdor Pharmacokinetics Under General Anesthesia

2020-004931-25Phase 4Completed

Sponsor
Turku University Hospital
Start
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of dexmedetomidine in knee osteoarthritis (OA) and hip osteoarthritis, sponsored by Turku University Hospital. Primary endpoint: Plasma dexmedetomidine concentration. Started Aug 2021; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

knee osteoarthritis (OA)hip osteoarthritis

Beyond the preview

Go deeper on 2020-004931-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-004931-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call